VolitionRx Past Earnings Performance
Past criteria checks 0/6
VolitionRx's earnings have been declining at an average annual rate of -17.1%, while the Medical Equipment industry saw earnings growing at 11.3% annually. Revenues have been growing at an average rate of 74.4% per year.
Key information
-17.1%
Earnings growth rate
-3.0%
EPS growth rate
| Medical Equipment Industry Growth | 8.9% |
| Revenue growth rate | 74.4% |
| Return on equity | n/a |
| Net Margin | -4,555.5% |
| Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
Recent updates
Do Institutions Own VolitionRx Limited (NYSEMKT:VNRX) Shares?
Mar 17
This Insider Has Just Sold Shares In VolitionRx Limited (NYSEMKT:VNRX)
Feb 10
Market Sentiment Around Loss-Making VolitionRx Limited (NYSEMKT:VNRX)
Jan 27Have Insiders Been Selling VolitionRx Limited (NYSEMKT:VNRX) Shares This Year?
Dec 29What Type Of Shareholders Own The Most Number of VolitionRx Limited (NYSEMKT:VNRX) Shares?
Nov 30Revenue & Expenses BreakdownBeta
How VolitionRx makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 1 | -35 | 17 | 20 |
| 30 Sep 23 | 1 | -34 | 18 | 18 |
| 30 Jun 23 | 1 | -33 | 17 | 18 |
| 31 Mar 23 | 0 | -31 | 18 | 16 |
| 31 Dec 22 | 0 | -30 | 17 | 15 |
| 30 Sep 22 | 0 | -31 | 18 | 15 |
| 30 Jun 22 | 0 | -30 | 20 | 12 |
| 31 Mar 22 | 0 | -28 | 17 | 13 |
| 31 Dec 21 | 0 | -27 | 15 | 13 |
| 30 Sep 21 | 0 | -24 | 12 | 14 |
| 30 Jun 21 | 0 | -21 | 8 | 15 |
| 31 Mar 21 | 0 | -21 | 7 | 15 |
| 31 Dec 20 | 0 | -20 | 7 | 15 |
| 30 Sep 20 | 0 | -19 | 6 | 13 |
| 30 Jun 20 | 0 | -19 | 6 | 13 |
| 31 Mar 20 | 0 | -18 | 6 | 12 |
| 31 Dec 19 | 0 | -16 | 6 | 10 |
| 30 Sep 19 | 0 | -17 | 6 | 11 |
| 30 Jun 19 | 0 | -17 | 6 | 11 |
| 31 Mar 19 | 0 | -18 | 6 | 11 |
| 31 Dec 18 | 0 | -18 | 7 | 11 |
| 30 Sep 18 | 0 | -18 | 7 | 10 |
| 30 Jun 18 | 0 | -17 | 7 | 10 |
| 31 Mar 18 | 0 | -16 | 7 | 9 |
| 31 Dec 17 | 0 | -15 | 7 | 8 |
| 30 Sep 17 | 0 | -14 | 6 | 8 |
| 30 Jun 17 | 0 | -13 | 6 | 8 |
| 31 Mar 17 | 0 | -13 | 5 | 8 |
| 31 Dec 16 | 0 | -12 | 5 | 8 |
| 30 Sep 16 | 0 | -12 | 5 | 7 |
| 30 Jun 16 | 0 | -11 | 4 | 7 |
| 31 Mar 16 | 0 | -10 | 4 | 6 |
| 31 Dec 15 | 0 | -10 | 4 | 6 |
| 30 Sep 15 | 0 | -8 | 3 | 6 |
| 30 Jun 15 | 0 | -11 | 3 | 5 |
| 31 Mar 15 | 0 | -8 | 3 | 4 |
| 31 Dec 14 | 0 | -8 | 2 | 4 |
| 30 Sep 14 | 0 | -8 | 2 | 3 |
| 30 Jun 14 | 0 | -3 | 2 | 3 |
| 31 Mar 14 | 0 | -5 | 2 | 3 |
| 31 Dec 13 | 0 | -4 | 2 | 3 |
| 30 Sep 13 | 0 | -4 | 2 | 3 |
| 30 Jun 13 | 0 | -4 | 1 | 3 |
Quality Earnings: VNRX is currently unprofitable.
Growing Profit Margin: VNRX is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: VNRX is unprofitable, and losses have increased over the past 5 years at a rate of 17.1% per year.
Accelerating Growth: Unable to compare VNRX's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: VNRX is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (2.9%).
Return on Equity
High ROE: VNRX's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.